 |
||||
|
||||
|
||||
|
||||
The Journal of Neuroscience, April 28, 2004, 24(17):4250-4258; doi:10.1523/JNEUROSCI.3920-03.2004
Previous Article | Next Article
Development/Plasticity/Repair
Early Striatal Dendrite Deficits followed by Neuron Loss with Advanced Age in the Absence of Anterograde Cortical Brain-Derived Neurotrophic Factor
Zachary C. Baquet, Jessica A. Gorski, andKevin R. Jones Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, Colorado 80309
Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, modulates neuronal survival, differentiation, and synaptic function. Reduced BDNF expression in the cortex caused by mutation of the huntingtin gene has been suggested to play a role in the striatal degeneration observed in Huntington's disease. BDNF expression rises dramatically in the cortex during the first few weeks of postnatal life in mice. Previously, it has been impossible to study the specific long-term effects of BDNF absence on CNS structures because of the early postnatal lethality of BDNF-/- mice. Mice harboring a floxed BDNF gene were bred with Emx1IREScre/+ mice to generate Emx-BDNFKO mice that lack cortical BDNF but are viable. Adult Emx-BDNFKO mice display a hindlimb clasping phenotype similar to that observed in mouse models of Huntington's disease. The striatum of postnatal Emx-BDNFKO mice was reduced in volume compared with controls, and the most abundant neuron type of the striatum, medium spiny neurons (MSNs), had shrunken cell somas, thinner dendrites, and fewer dendritic spines at 35 d of age. Although significant striatal neuron losses were not detected at 35 or 120 d postnatal, 35% of striatal neurons were missing in Emx-BDNFKO mice aged beyond 1 year. Thus, cortical BDNF, although not required for the generation or near-term survival of MSN, is necessary for normal striatal neuron dendrite morphology during the period when BDNF expression rises in the cortex. Furthermore, a long-term in vivo requirement for cortical BDNF in supporting the survival of MSNs is revealed.
Key words: BDNF; Huntington's disease; dendrite; striatum; Cre-lox; neurotrophin; mouse; mutant
Received Aug 22, 2003; revised March 25, 2004; accepted March 25, 2004.
This article has been cited by other articles:
T. B. Brown, A. I. Bogush, and M. E. Ehrlich
Neocortical expression of mutant huntingtin is not required for alterations in striatal gene expression or motor dysfunction in a transgenic mouse
Hum. Mol. Genet., October 15, 2008; 17(20): 3095 - 3104.
[Abstract] [Full Text] [PDF]
H. Seo, W. Kim, and O. Isacson
Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patients
Hum. Mol. Genet., October 15, 2008; 17(20): 3144 - 3153.
[Abstract] [Full Text] [PDF]
M. Gray, D. I. Shirasaki, C. Cepeda, V. M. Andre, B. Wilburn, X.-H. Lu, J. Tao, I. Yamazaki, S.-H. Li, Y. E. Sun, et al.
Full-Length Human Mutant Huntingtin with a Stable Polyglutamine Repeat Can Elicit Progressive and Selective Neuropathogenesis in BACHD Mice
J. Neurosci., June 11, 2008; 28(24): 6182 - 6195.
[Abstract] [Full Text] [PDF]
R. Zivadinov, B. Weinstock-Guttman, R. Benedict, M. Tamano-Blanco, S. Hussein, N. Abdelrahman, J. Durfee, and M. Ramanathan
Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor
Hum. Mol. Genet., November 15, 2007; 16(22): 2659 - 2668.
[Abstract] [Full Text] [PDF]
A. D. Strand, Z. C. Baquet, A. K. Aragaki, P. Holmans, L. Yang, C. Cleren, M. F. Beal, L. Jones, C. Kooperberg, J. M. Olson, et al.
Expression Profiling of Huntington's Disease Models Suggests That Brain-Derived Neurotrophic Factor Depletion Plays a Major Role in Striatal Degeneration
J. Neurosci., October 24, 2007; 27(43): 11758 - 11768.
[Abstract] [Full Text] [PDF]
D. Rigamonti, D. Bolognini, C. Mutti, C. Zuccato, M. Tartari, F. Sola, M. Valenza, A. G. Kazantsev, and E. Cattaneo
Loss of Huntingtin Function Complemented by Small Molecules Acting as Repressor Element 1/Neuron Restrictive Silencer Element Silencer Modulators
J. Biol. Chem., August 24, 2007; 282(34): 24554 - 24562.
[Abstract] [Full Text] [PDF]
S. M. Mooney and M. W. Miller
Postnatal Generation of Neurons in the Ventrobasal Nucleus of the Rat Thalamus
J. Neurosci., May 9, 2007; 27(19): 5023 - 5032.
[Abstract] [Full Text] [PDF]
J. P. Dompierre, J. D. Godin, B. C. Charrin, F. P. Cordelieres, S. J. King, S. Humbert, and F. Saudou
Histone Deacetylase 6 Inhibition Compensates for the Transport Deficit in Huntington's Disease by Increasing Tubulin Acetylation
J. Neurosci., March 28, 2007; 27(13): 3571 - 3583.
[Abstract] [Full Text] [PDF]
H. Fukumitsu, M. Ohtsuka, R. Murai, H. Nakamura, K. Itoh, and S. Furukawa
Brain-Derived Neurotrophic Factor Participates in Determination of Neuronal Laminar Fate in the Developing Mouse Cerebral Cortex
J. Neurosci., December 20, 2006; 26(51): 13218 - 13230.
[Abstract] [Full Text] [PDF]
S. Murase and R. D. McKay
A specific survival response in dopamine neurons at most risk in Parkinson's disease.
J. Neurosci., September 20, 2006; 26(38): 9750 - 9760.
[Abstract] [Full Text] [PDF]
A. L. Sanchez, B. J. Matthews, M. M. Meynard, B. Hu, S. Javed, and S. Cohen-Cory
BDNF increases synapse density in dendrites of developing tectal neurons in vivo
Development, July 1, 2006; 133(13): 2477 - 2486.
[Abstract] [Full Text] [PDF]
G. L. Dunbar, M. I. Sandstrom, J. Rossignol, and L. Lescaudron
Neurotrophic Enhancers as Therapy for Behavioral Deficits in Rodent Models of Huntington's Disease: Use of Gangliosides, Substituted Pyrimidines, and Mesenchymal Stem Cells.
Behav Cogn Neurosci Rev, June 1, 2006; 5(2): 63 - 79.
[Abstract] [PDF]
V. M. Andre, C. Cepeda, A. Venegas, Y. Gomez, and M. S. Levine
Altered Cortical Glutamate Receptor Function in the R6/2 Model of Huntington's Disease
J Neurophysiol, April 1, 2006; 95(4): 2108 - 2119.
[Abstract] [Full Text] [PDF]
Z. C. Baquet, P. C. Bickford, and K. R. Jones
Brain-Derived Neurotrophic Factor Is Required for the Establishment of the Proper Number of Dopaminergic Neurons in the Substantia Nigra Pars Compacta
J. Neurosci., June 29, 2005; 25(26): 6251 - 6259.
[Abstract] [Full Text] [PDF]
W. Akamatsu, H. Fujihara, T. Mitsuhashi, M. Yano, S. Shibata, Y. Hayakawa, H. J. Okano, S.-i. Sakakibara, H. Takano, T. Takano, et al.
The RNA-binding protein HuD regulates neuronal cell identity and maturation
PNAS, March 22, 2005; 102(12): 4625 - 4630.
[Abstract] [Full Text] [PDF]
L. Pezawas, B. A. Verchinski, V. S. Mattay, J. H. Callicott, B. S. Kolachana, R. E. Straub, M. F. Egan, A. Meyer-Lindenberg, and D. R. Weinberger
The Brain-Derived Neurotrophic Factor val66met Polymorphism and Variation in Human Cortical Morphology
J. Neurosci., November 10, 2004; 24(45): 10099 - 10102.
[Abstract] [Full Text] [PDF]
J. M. Canals, J. R. Pineda, J. F. Torres-Peraza, M. Bosch, R. Martin-Ibanez, M. T. Munoz, G. Mengod, P. Ernfors, and J. Alberch
Brain-Derived Neurotrophic Factor Regulates the Onset and Severity of Motor Dysfunction Associated with Enkephalinergic Neuronal Degeneration in Huntington's Disease
J. Neurosci., September 1, 2004; 24(35): 7727 - 7739.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|